Fukami, S., Tomioka, D., Murakami, Y., Honda, T., & Hatakeyama, S. (2019). Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models. BMC Res Notes.

Fukami, Shigemi, Daisaku Tomioka, Yutaka Murakami, Toshiyuki Honda, και Shinji Hatakeyama. "Pharmacological Profiling of a Dual FAK/IGF-1R Kinase Inhibitor TAE226 in Cellular and in Vivo Tumor Models." BMC Res Notes 2019.

Fukami, Shigemi, et al. "Pharmacological Profiling of a Dual FAK/IGF-1R Kinase Inhibitor TAE226 in Cellular and in Vivo Tumor Models." BMC Res Notes 2019.